...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: BETonMACE ClinicalTrials.gov update

Just a minor update this week to the BETonMACE ClinicalTrials.gov listing.

The estimated study completion date was changed from "June 2019 [Anticipated]" to "November 30, 2019 [Anticipated]"

I don't think this really means anything. Anticipated dates are very often off from the actual date. And "study completion" is quite vague. Perhaps the study isn't complete until full results are presented and published in November 2019 at AHA and/or ASN?


New Message
Please login to post a reply